News & Events about Vir Biotechnology Inc.
Vir Biotechnology, Inc. (NASDAQ:VIR Get Rating) major shareholder Endurance (Cayman) Ltd Svf sold 36,512 shares of the stock in a transaction dated Monday, January 23rd. The shares were sold at an average price of $28.34, for a total value of $1,034,750.08. Following the sale, the insider ...
Vir Biotechnology, Inc. (NASDAQ:VIR Get Rating) insider Phillip Pang sold 30,000 shares of Vir Biotechnology stock in a transaction dated Tuesday, January 24th. The shares were sold at an average price of $30.00, for a total value of $900,000.00. Following the completion of the transaction, ...
Vir Biotechnology, Inc. (NASDAQ:VIR Get Rating) major shareholder Endurance (Cayman) Ltd Svf sold 69,839 shares of the companys stock in a transaction dated Thursday, January 19th. The shares were sold at an average price of $26.56, for a total transaction of $1,854,923.84. Following ...
Dr. De Backer to assume CEO role on April 3, 2023 Upon his retirement as CEO, Dr. Scangos will transition to an advisory role through June 2, 2023 and will continue providing strategic to Vir as a member of the Board of Directors SAN FRANCISCO, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, ...
Vir Biotechnology, Inc. (NASDAQ:VIR Get Rating) major shareholder Endurance (Cayman) Ltd Svf sold 88,372 shares of the companys stock in a transaction that occurred on Tuesday, January 17th. The shares were sold at an average price of $26.24, for a total value of $2,318,881.28. Following the ...